Foundation News

The Crohn’s & Colitis Foundation received a grant from the Centers for Disease Control and Prevention (CDC) titled “Improving Health Outcomes for Patients with Inflammatory Bowel Disease.” The grant will support a comprehensive five-year project in collaboration with the University of Alabama at Birmingham (UAB) aimed at identifying and addressing barriers to medical diagnosis and care of patients with inflammatory bowel disease, emphasizing the experience and impact on African American adults and adolescents.

UnitedHealthcare (UHC) has delayed implementing a new policy that would have required prior authorization for most physician-prescribed endoscopy and colonoscopy procedures, which was slated to begin June 1. This decision comes after UHC faced significant backlash from the GI community, and a rally was led by the Crohn's & Colitis Foundation alongside IBD healthcare professionals and patients outside UHC’s Minnesota headquarters on May 31. The Foundation was invited to meet with UHC to discuss the policy after the rally.

Using collective data made available by IBD Plexus, researchers’ findings advance the possibility of microbiome-based personalized medicine for IBD treatment.

Legislation will give patients and their doctors a process to seek exception to Step Therapy requirements that may delay necessary care

The Crohn's & Colitis Foundation advocates for reform in the Pharmacy Benefit Manager (PBM) industry due to the negative impact it has on patients' access to medicine.

Last week, in an unprecedented decision, a Texas federal judge invalidated the Food and Drug Administration’s (FDA) approval of a drug that was approved by the agency in 2000.

April 3, 2023, New York, NY – Last week, the U.S. Equal Employment Opportunity Commission (EEOC) sued Walmart for firing a North Carolina employee with Crohn’s disease after the company allegedly refused to grant her disability-related leave.

Since 2017, IBD Ventures Has Invested Over $9 Million In R&D Funding to Portfolio Companies

New York, NY, March 14, 2023 – Early life stress (ELS) in mice can disrupt the gut immune response, leading to longer-lasting intestinal inflammation and a worsened future disease state than control mice not exposed to ELS, according to a new study published in Inflammatory B